GSK publishes Prospectus and Circular for proposed demerger

Further to the announcement made earlier today regarding the proposed separation of the GSK Consumer Healthcare business from the GSK Group, GSK confirms that the Circular in relation to the proposed demerger (the “Demerger”)  and the Prospectus in relation to the admission of Haleon plc’s ordinary shares to the Premium listi

Related Keywords

United Kingdom , Heathrow , Hillingdon , London , City Of , Haleon Adss , York Stock Exchange , United Kingdom National Storage Mechanism , Main Market Of The London Stock Exchange , List Of The Financial Conduct Authority , Party Transactions , Transparency Rules Of The Financial Conduct Authority , Official List , Financial Conduct Authority , Main Market , London Stock Exchange , National Storage Mechanism , Related Party Transactions , General Meeting , Sofitel London Heathrow , London Heathrow Airport , American Depositary Shares , New York Stock Exchange , Market Abuse Regulation , United Kingdom Listing Rules , Disclosure Guidance , Transparency Rules , Risk Factor , Board Of Directors , Forward Looking Statement , Nasdaq , Pharmaceuticals , Prospectus , Us Securities And Exchange Commission , Swadss , American Depositary Receipt , Articles , Demerger , Glaxosmithkline ,